Related Experiment Videos
p73 induces apoptosis by different mechanisms.
Saafa Ramadan1, Alessandro Terrinoni, Maria Valeria Catani
1Laboratory of Biochemistry and Molecular Biology, IRCCS-Fondazione Santa Lucia, Via Ardeatina 306, 00179 Rome, Italy.
Summary
The tumor suppressor p73 protein can trigger apoptosis, a key factor in cancer therapy. Its isoforms, TAp73 and DeltaNp73, have opposing roles, and their balance influences cancer prognosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- The p73 protein, a homolog of p53, plays a role in apoptosis and cancer.
- The TAp73 gene generates two isoforms, TAp73 (pro-apoptotic) and DeltaNp73 (anti-apoptotic), influencing cancer prognosis.
Purpose of the Study:
- To review recent advancements in understanding p73-induced apoptosis.
- To elucidate the mechanisms by which TAp73 regulates apoptosis through various cellular pathways.
Main Methods:
- Analysis of TAp73's role in endoplasmic reticulum (ER) stress induction.
- Investigation of TAp73's impact on the mitochondrial apoptosis pathway.
- Exploration of TAp73's potential activation of the death receptor pathway.
- Examination of TAp73's self-regulation of DeltaNp73 expression.
Main Results:
- TAp73 induces ER stress via Scotin transactivation.
- TAp73 strongly transactivates the PUMA promoter, inducing the mitochondrial pathway and apoptosis.
- TAp73 may activate the death receptor pathway (CD95).
- TAp73 transactivates its own promoter, leading to DeltaNp73 expression.
Conclusions:
- The balance between TAp73 and DeltaNp73 isoforms is critical in regulating cellular apoptosis.
- Understanding these pathways offers insights into cancer development and therapeutic strategies.